Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.14
(
0.93%
)
Bitcoin
68,684.07
(
1.25%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: linhdtu post# 175906

Monday, 03/24/2014 2:57:00 PM

Monday, March 24, 2014 2:57:00 PM

Post# of 257269
Due to GILD’s including a mix of GT1a/GT1b in all three ‘ION’ studies and its including a mix of cirrhotic/non-cirrhotic patients in ION-1 and ION-2 (#msg-96696670), EASL will afford ample opportunities for investors to argue the relative merits of the two datasets based on various criteria. It should keep this board pretty active for a few days!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today